EE200000137A - Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena - Google Patents

Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena

Info

Publication number
EE200000137A
EE200000137A EEP200000137A EEP200000137A EE200000137A EE 200000137 A EE200000137 A EE 200000137A EE P200000137 A EEP200000137 A EE P200000137A EE P200000137 A EEP200000137 A EE P200000137A EE 200000137 A EE200000137 A EE 200000137A
Authority
EE
Estonia
Prior art keywords
inhibitors
neutrophil elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
EEP200000137A
Other languages
English (en)
Inventor
Andrew Harrison Lee
George Adam Inglis Graham
Redpath Johnson Martin
John Fawcett Macdonald Simon
Dennis Dowle Michael
Finch Harry
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE200000137A publication Critical patent/EE200000137A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
EEP200000137A 1997-09-09 1998-09-07 Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena EE200000137A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9719187.8A GB9719187D0 (en) 1997-09-09 1997-09-09 Compounds
PCT/EP1998/005604 WO1999012931A1 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (1)

Publication Number Publication Date
EE200000137A true EE200000137A (et) 2001-02-15

Family

ID=10818820

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000137A EE200000137A (et) 1997-09-09 1998-09-07 Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena

Country Status (24)

Country Link
US (1) US6228853B1 (et)
EP (1) EP1019406A1 (et)
JP (1) JP2001515902A (et)
KR (1) KR20010023830A (et)
CN (1) CN1278821A (et)
AP (1) AP2000001760A0 (et)
AU (1) AU9536098A (et)
BR (1) BR9811651A (et)
CA (1) CA2303249A1 (et)
EA (1) EA200000205A1 (et)
EE (1) EE200000137A (et)
GB (1) GB9719187D0 (et)
HR (1) HRP20000136A2 (et)
HU (1) HUP0003475A3 (et)
ID (1) ID24364A (et)
IL (1) IL134935A0 (et)
IS (1) IS5394A (et)
MA (1) MA26544A1 (et)
NO (1) NO20001200L (et)
PL (1) PL339186A1 (et)
SK (1) SK3242000A3 (et)
TR (1) TR200001026T2 (et)
WO (1) WO1999012931A1 (et)
ZA (1) ZA988162B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
US7745226B2 (en) 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
US7972868B2 (en) 2007-11-28 2011-07-05 Quest Diagnostics Investments Incorporated Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
US7977117B2 (en) 2009-12-03 2011-07-12 Quest Diagnostics Investments Incorprated Vitamin D metabolite determination utilizing mass spectrometry following derivatization
US9034653B2 (en) 2009-12-11 2015-05-19 Quest Diagnostics Investments Inc. Mass spectrometry of steroidal compounds in multiplexed patient samples
US20120025067A1 (en) 2009-12-11 2012-02-02 Quest Diagnostics Investments Incorporated Mass spectrometric determination of non-derivatized, non-metabolized vitamin d
KR20220079527A (ko) 2019-09-17 2022-06-13 메레오 바이오파마 4 리미티드 이식편 거부반응, 폐쇄성 세기관지염 증후군 및 이식편 대 숙주병의 치료에 사용하기 위한 알베레스타트
AU2021256835A1 (en) 2020-04-16 2022-10-13 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983245A (en) 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes
GB8512230D0 (en) 1985-05-14 1985-06-19 Shell Internationale Researche Preparation of carboxylic acid salt
GB9211783D0 (en) 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
AU715229B2 (en) * 1996-01-03 2000-01-20 Smithkline Beecham Plc Carbamoyloxy derivatives of mutiline and their use as antibacterials
EP0891362B1 (en) * 1996-03-28 2004-03-17 Glaxo Group Limited Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Also Published As

Publication number Publication date
EA200000205A1 (ru) 2000-10-30
SK3242000A3 (en) 2001-03-12
ID24364A (id) 2000-07-13
MA26544A1 (fr) 2004-12-20
ZA988162B (en) 2000-03-22
HUP0003475A3 (en) 2002-01-28
NO20001200D0 (no) 2000-03-08
BR9811651A (pt) 2000-08-08
TR200001026T2 (tr) 2000-09-21
AP2000001760A0 (en) 2000-03-31
KR20010023830A (ko) 2001-03-26
CA2303249A1 (en) 1999-03-18
WO1999012931A1 (en) 1999-03-18
PL339186A1 (en) 2000-12-04
CN1278821A (zh) 2001-01-03
IS5394A (is) 2000-03-03
GB9719187D0 (en) 1997-11-12
US6228853B1 (en) 2001-05-08
IL134935A0 (en) 2001-05-20
HUP0003475A2 (hu) 2001-09-28
EP1019406A1 (en) 2000-07-19
AU9536098A (en) 1999-03-29
NO20001200L (no) 2000-05-08
HRP20000136A2 (en) 2000-08-31
JP2001515902A (ja) 2001-09-25

Similar Documents

Publication Publication Date Title
EE9800335A (et) Pürrolopürrolooni derivaadid kui neutrofiilelastaasi inhibiitorid
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
FI944804A0 (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
ATE224366T1 (de) D-prolinderivate
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
EE200000138A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
PT927183E (pt) Inibidores espirociclicos de metaloproteases
FI973211A0 (fi) Ihmisen leukosyyttielastaasin inhibiittoreina hyödylliset proliinijohdannaiset
DE69736109D1 (de) Differenzierungsinhibitor
EE200000137A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
DE69733263D1 (de) Markierte elastase-inhibitoren
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
ATE221065T1 (de) Amidinderivate als inhibitoren von no-synthase
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
EE200100084A (et) NOS inhibiitorite uued farmatseutilised kasutusvoimalused
EE9900585A (et) 6-asauratsiili derivaadid IL-5 inhibiitoritena
ID23866A (id) Komposisi untuk menyelamatkan beras terhadap asetoklor
ZA988160B (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
SI0891362T1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
DE69418656T2 (de) 2-acyloxycephemderivate als elastaseinhibitoren
PT1062392E (pt) Obra de passagem sob terrapleno
ITMI951551A0 (it) Composizioni orosolubili di n-acetilcisteina
ITRM980261A0 (it) Innovati mezzi di navigazioe